OTCMKTS:ANTB (ANTB) (ANTB) Stock Price, News & Analysis → AI healthcare stock poised for 36,996% growth? (From Behind the Markets) (Ad) Free ANTB Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.81▼$0.8350-Day Range N/A52-Week Range$0.75▼$1.25Volume2,100 shsAverage Volume8,783 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (ANTB) alerts: Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About (ANTB)Rezolute, Inc. is biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. Its products portfolio include RZ358-Phase 2, an antibody for the ultra-orphan indication of congenital hyperInsulinism; AB101-Phase 1, a once-weekly injectable basal insulin; and RZ402 which targets diabetic macular edema. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada on July 26, 2010 and is headquartered in Redwood City, CA.Read More Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… ANTB Stock News HeadlinesFebruary 1, 2024 | morningstar.comAerodrom Nikola Tesla ad AEROAugust 16, 2023 | msn.comBest watering bells: How to use Chantepleure watering cans to keep your plants thrivingMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.May 5, 2023 | msn.comBindi Irwin’s Daughter Grace Has the Cutest Gap-Toothed Smile in New Photo With Uncle RobertApril 26, 2023 | msn.comZay Flowers wasn’t about to pass on a chance to work with Patrick MahomesApril 26, 2023 | msn.comCompany news: Syracuse University Libraries promotes Ronald FigueroaApril 7, 2023 | msn.comUkraine discusses preventing military leaks after report of breachMarch 28, 2023 | msn.comBhopal: Madhya Pradesh cabinet approves Kaushal Vikas YojanaMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.February 16, 2023 | msn.comShots fired call in Shelburn leads to arrestFebruary 6, 2023 | msn.comP&P: What makes coaching Texans DeMeco Ryans' dream job?January 10, 2023 | msn.comNeighbors come to rescue of man stabbed outside south Las Vegas valley homeJanuary 10, 2023 | msn.comHalf of city GBV victims ‘refuse’ to open cases against abusersOctober 20, 2022 | msn.comVincent Kompany gushes about Birmingham City's transfer deals with big relegation predictionAugust 1, 2022 | msn.comShooting at pub car park, faces of jailed criminals and M57 set to closeJuly 12, 2022 | msn.comThese incredible Roman ruins are still standing todayJune 10, 2022 | msn.comTravel back in time: Roman ruins that have been preservedApril 27, 2022 | msn.comRemarkable Roman ruins still standingNovember 3, 2021 | nasdaq.comThe total return for Bank of N.T. Butterfield & Son (NYSE:NTB) investors has risen faster than earnings growth over the last five yearsNovember 1, 2021 | msn.comCall Of Duty: Vanguard… A new story beginsOctober 29, 2021 | msn.comBeautiful Roman ruins everyone should seeSeptember 24, 2021 | msn.comStaggering Roman ruins still standingAugust 23, 2021 | msn.comThe world's most beautiful Roman ruins everyone should seeSee More Headlines Receive ANTB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (ANTB) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorComputer and Technology Industry Internet Software & Services Sub-IndustryN/A Current SymbolOTCMKTS:ANTB CUSIPN/A CIK1509261 Webwww.rezolutebio.com Phone(650) 206-4507FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesNevan Charles ElamPresident, Chief Executive Officer, CFO & DirectorMichael DeperroHead-OperationsSankaram MantripragadaChief Scientific OfficerErin O’BoyleHead-Clinical OperationsDavelyn HoodDirector-Scientific & Patient AffairsKey CompetitorsAnalytica Bio-EnergyOTCMKTS:ABECGameSquare EsportsOTCMKTS:GMSQFTikcro TechnologiesOTCMKTS:TIKRF(UPGI)OTCMKTS:UPGI01 Communique LaboratoryOTCMKTS:OCQLFView All Competitors ANTB Stock Analysis - Frequently Asked Questions What other stocks do shareholders of (ANTB) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (ANTB) investors own include Allena Pharmaceuticals (ALNA), Novavax (NVAX), Rite Aid (RAD), Ampliphi Biosciences (APHB), LendingClub (LC), SunPower (SPWR), Sorrento Therapeutics (SRNE), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF) and AcelRx Pharmaceuticals (ACRX). This page (OTCMKTS:ANTB) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingInvestors Alert: The Next Big Thing in Weight LossBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryFed launches fourth dollar overhaulStansberry ResearchThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (ANTB) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.